Omada Health, Inc.
OMDAHealthcareNASDAQHealth Information Services · Last scanned May 28, 2026
Scan Results
Daily timeframe1 of 4 indicators bearish as of May 27
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. Valued at $978.5M, OMDA is a small-cap name in its sector. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Market Cap
$978.5M
Beta
—
P/E (TTM)
—
P/E (Fwd)
34.55
EPS (TTM)
$-0.23
EPS (Fwd)
$0.48
ROE
-4.3%
ROA
-2.4%
Cash
$211.8M
Total Debt
$0
Free CF
$16.8M
52W Change
-28.4%
Annual Financials
Cash vs Debt
Omada Health, Inc. reports $211.8M in cash and $0 in total debt. The company generates $16.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -4.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $89.2M (2022) to $260.2M (2025), reflecting a 192% increase over the period.
Investors considering Omada Health, Inc. should weigh the typical risks associated with OMDA's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing OMDA.